Document is current
Any future updates will be listed below
-
Authors
Shichino, Shigeyuki https://orcid.org/0000-0002-1683-2448
Ueha, Satoshi
Hashimoto, Shinichi https://orcid.org/0000-0002-1223-2349
Ogawa, Tatsuro
Aoki, Hiroyasu
Wu, Bin
Chen, Chang-Yu
Kitabatake, Masahiro
Ouji-Sageshima, Noriko
Sawabata, Noriyoshi
Kawaguchi, Takeshi
Okayama, Toshitugu
Sugihara, Eiji https://orcid.org/0000-0002-3233-1045
Hontsu, Shigeto
Ito, Toshihiro
Iwata, Yasunori
Wada, Takashi
Ikeo, Kazuho
Sato, Taka-Aki
Matsushima, Kouji https://orcid.org/0000-0003-1056-171X
- License Information
-
More Information
Article History
Received: 28 September 2021
Accepted: 27 May 2022
First Online: 27 June 2022
Competing interests
: S.S. reports advisory role for ImmunoGeneTeqs, Inc; stock for ImmunoGeneTeqs, Inc, S.U. reports advisory role for ImmunoGeneTeqs, Inc; stock for ImmunoGeneTeqs, Inc, IDAC Theranostics, Inc. H.A. reports stock for ImmunoGeneTeqs, Inc., K.M. reports consulting or advisory role for Kyowa-Hakko Kirin, ImmunoGeneTeqs, Inc; research funding from Kyowa-Hakko Kirin, and Ono; stock for ImmunoGeneTeqs, Inc, IDAC Theranostics, Inc., T.I. reports consulting or advisory role for ROHTO Pharmaceutical Co., Ltd; research funding from ROHTO Pharmaceutical Co., Ltd. All the other authors declare no competing interests.
